BloombergNEF says in a new report that global clean energy investment reached $2.1 trillion in 2024, more than doubling 2020 ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that will make the kidney disease drug developer the first U.S. biotech ...

(Reuters) -Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed ...

A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care first-time share sales since October.Most Read from BloombergManhattan’s Morning ...

A report on energy transition investments from BloombergNEF showed that global investment in clean energy technologies hit a ...

Pimco, one of the world’s largest bond managers, owns 354 million Class A shares of Venture Global (VG), the natural-gas exporter that went ...

Shares in Venture Global are expected to make their debut on the New York Stock Exchange after the company raised $1.75 ...

Bond manager’s $7 billion stake in Venture Global latest sign that traditional asset managers are making inroads investing in ...

Baker Hughes has been awarded a major contract to provide a modularised liquefied natural gas (LNG) system and power island to support Venture Global (VG) LNG projects in the US.

That means Mr. Liang had a cornucopia of technical talent at his disposal, all galvanized by the challenge of doing AI ...

The company has also signed a services frame agreement to support phase 1 and 2 of the Venture Global's Plaquemines LNG ...

Taking yet another step in its preparations for its IPO, B2B marketplace unicorn OfBusiness has converted itself into a ...